Microbiological analysis as effective tool for optimization of empirical antibiotic therapy in the urological clinic


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim: to study the features of microbiota in patients of urological departments and to optimize the schemes of antibiotic therapy. Materials and methods. Data of microbiological studies in patients of urological departments in 2017 years were analyzed. Isolation of pathogens was carried out using standard techniques. A disk diffusion test using Mueller-Hinton agar with BioRad disks was used to determine the sensitivity. The statistical analysis was performed using the WHONET 5.4 program. In addition, a comparison with the results of the PCR study was done. Results. A total of 672 etiological pathogens were isolated in whole clinic in 2017 year. From those, 173 pathogens were found in the urological clinic, which accounted for 25.7% of the total number. Gram-negative bacteria predominated and its proportion was 59.23%. Gram-positive bacteria were isolated in 24.4%, and fungi were found in 16.37% of cases. The structure of pathogens isolated from stoma or obtained by catheterization was not significantly different. Most frequently isolated pathogens included @K. pneumonia (22.8%), @E. coli (21.2%), @C. albicans (17%), @P. aeruginosa (11%), @E. aerogenes (6%) and @S. aureus (3 %). @K. pneumonia usually had an unfavorable resistance pattern. E. coli isolated from urine samples had more favorable resistance pattern in comparison to pathogens obtained from stoma. The bacteria which were found in intensive care unit had the increased level of resistance. Conclusion. Gram-negative bacteria predominate in the urological clinic with a relatively high proportion of extended-spectrum beta-lactamase producing organisms. Risk factors for the emergence of multi-resistant pathogens are the treatment in the intensive care unit and the presence of stomas or catheters. The PCR method, carried out in parallel with routine microbiological studies and regular analysis of the overall bacterial spectrum, allows to optimize the starting antibiotic therapy from the first day of the disease. The use of cephalosporins is not justified in the most cases. Aminoglycosides and fluoroquinolones remain effective. The use of either β-Lactamase-protected penicillins or fosfomycin is possible only after obtaining the results of bacteriological study. When prescribing carbapenems, the risk of inefficiency is especially high in patients with stomas/catheters and transferred from the intensive care unit.

Full Text

Restricted Access

About the authors

D. N Pisanenko

Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation

Email: Den.pisanencko@yandex.ru
Ph.D. student at the Department of Management and Economic of Pharmacy and Pharmaceutic Technology

V. E Gasrataliev

Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation

Email: Gasrataliev@pomc.ru
Ph.D., urologist, assistant at the Department of Faculty Surgery and Transplantology

T. N Gorshkova

Volga District Medical Centre under Federal Medical and Biological Agency of Russia

Email: Gorchkova@gmail.com
Chief specialist on Clinical Laboratory Diagnostic, Head of Department of Clinical and Laboratory Diagnostic

M. V Ivaneeva

Volga District Medical Centre under Federal Medical and Biological Agency of Russia

Email: Ivaneevam@mail.ru
doctor of clinical laboratory diagnostics of Clinical and Laboratory Diagnostic

D. V Abramov

Volga District Medical Centre under Federal Medical and Biological Agency of Russia

Email: Gtv74@mail.ru
head of Urological department № 2 of Urological Clinic

A. A Danilov

Volga District Medical Centre under Federal Medical and Biological Agency of Russia

Email: Abramov@pomc.ru
Head of Department of Urology № 1 of Urological Clinic

T. V Galitsky

Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation

Email: Danilov@pomc.ru
Ph.D., urologist, teaching assistant at the Department of Urology named after E.V. Shakhov

O. V Ruina

Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation; Volga District Medical Centre under Federal Medical and Biological Agency of Russia

Email: Olga-ru1@yandex.ru
Ph.D., clinical pharmacologist; assistant professor at the Department of General and Clinical Pharmacology

A. B Stroganov

Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation

Email: Stroganov@pimunn.ru
Dr.Med.Sci. assistant professor at the Department of Faculty Surgery and Transplantology

V. A Atduev

Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation; Volga District Medical Centre under Federal Medical and Biological Agency of Russia

Email: Atduev@mail.ru
Dr.Med.Sci, prof., Head of Urological Clinic; Chief Urologist of Ministry of Health of Nizhny Novgorod region, professor at the Department of Faculty Surgery and Transplantology

References

  1. Козлов С.Н., Козлов Р.С. Современная антимикробная химиотерапия: Руководство для врачей. 3-е изд.; перераб. и доп. М.: Медицинское информационное агентство. 2017; 400 с.
  2. Гилберт Д.Г., Мёллеринг Р. и др. Антимикробная терапия по Джею Сэнфорду. Пер. с англ. под ред. Ю.Б. Белоусова, В.В. Никифорова и А.И. Мазуса. М: ГРАНАТ. 2013; 640 с.
  3. Стратегия и тактика применения антимикробных средств в лечебных учреждениях России: Российские национальные рекомендации. Под ред. В.С. Савельева, Б.Р. Гельфанда, С.В. Яковлева. М: Компания «БОРГЕС». 2012; 92 с. Текст рекомендаций представлен на сайте www.antimicrob.net
  4. Перепанова Т.С. Федеральные клинические рекомендации «Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов - 2015 г.». Терапевтический архив. 2016; 4 (88):100-104 р.) doi: 10.17116/terarkh2016884100-104.
  5. Программа СКАТ "Стратегия Контроля Антимикробной Терапии" при оказании стационарной медицинской помощи. Методические рекомендации для лечебно-профилактических учреждений Москвы. [С.В. Яковлев, М.В. Журавлёва, Д.Н. Проценко и др.]. Consilium Medicum, 2017; 7 (1):131
  6. Naber K.G., Bergman B., Bishop M.C. et al. Guidelines on Urinary and Male Genital Tract Infections European Association of Urology. 2011; 115 p.
  7. Распоряжение Правительства Российской Федерации от 25.09.2017 № 2045-р «Стратегия предупреждения распространения антимикробной резистентности в Российской Федерации на период до 2030 года»
  8. Брико Н.Н., Ковалишена О.В., Полибин Р.В. Деятельность Национальной ассоциации специалистов по контролю инфекций, связанных с оказанием медицинской помощи. Эпидемиология и вакцинопрофилактика. 2017;6 (97)16:79-83
  9. European Centre for Disease Prevention and Control. Annual Epidemiological Report 2016 - Healthcare-associated infections acquired in intensive care units. Stockholm: ECDC; 2016. Доступно на: http:// ecdc.europa.eu/sites/portal/files/document/AER-HCAI_ICU_3_0.pdf.
  10. Барканова О.Н. Антибактериальная терапия в урологии. Лекарственный вестник. 2011;1 (41):10-19
  11. Кузьмичев Б.Ю. и др. Анализ антибиотикорезистентности у больных урологического профиля. Научно-методический электронный журнал «Концепт». 2016;15:676-680). URL: http://e-koncept.ru/2016/96044.htm.
  12. Бабаев С.Ю. Сравнительный мониторинг антибиотико-резистентности микрофлоры многопрофильных стационаров в городах Пенза и Нижний Новгород. Медицинский альманах. 2016;3(43):67-70
  13. Гасраталиев В.Э., Атдуев В.А. и др. Роль инфекции в развитии осложнений после радикальной цистэктомии. Медицинский альманах. 2017;5(50):175-180
  14. Kumar G., Kumar N. et al. Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest. 2011;140 (5):1223-1231.
  15. Припутневич Т.В. Использование методов MALDI-TOF масс-спектрометрии и количественной ПЦР для быстрой диагностики септических состояний. Клиническая Микробиология и Антимикробная Химиотерапия. 2014;16(1):4-9

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies